Inventor
Felix HERTH
Inventor
DE
Overview
Patents· 2 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
G01Nprimary
G01NInvestigating or analysing materials by determining their chemical or physical properties67%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms33%
PatentTitleYear
12,571,050Method of predicting response to therapy by assessing tumor genetic heterogeneity202611,402,381Methods of identifying an individual to be treated by chemotherapy based on cytokeratin-19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) marker molecules and related uses2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022Patents assigned to ROCHE DIAGNOSTICS OPERATIONS INC (1)· patent assignee history
2022–2026Based in DE· patent location history
2026Patents assigned to ROCHE SEQUENCING SOLUTIONS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ROCHE DIAGNOSTICS OPERATIONS INC | 1 | 2022 |
| ROCHE SEQUENCING SOLUTIONS INC | 1 | 2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| DE | 2 | 2022–2026 |